Study of SM-7338 in the treatment of bacterial meningitis
Phase 3
- Conditions
- Bacterial meningitis
- Registration Number
- JPRN-jRCT2080221609
- Lead Sponsor
- Dainippon Sumitomo Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with clinical symptoms and findings in cerebrospinal fluid of bacterial meningitis
- Inpatients
Exclusion Criteria
- Patients with history of hypersensitivity to carbapenem,penicillin or cephem antibiotic
- Patients with severe hepatic function or renal function
- Patients with epilepsia or history of epilepsia
- Patients with treatment of sodium valproate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical response<br>At the point of end of treatment
- Secondary Outcome Measures
Name Time Method Microbiological response<br>At the point of end of treatment and follow up